ROTE WILLIAM E. bought TVTX
September 15, 2026 · Form 4 insider transaction
ROTE WILLIAM E. bought 39,000 shares of Travere Therapeutics, Inc. at $25.25 per share, a transaction worth $984.8K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
39,000
Price
$25.25
Total value
$984.8K
InsiderROTE WILLIAM E.
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateSeptember 15, 2026
Filing dateSeptember 17, 2026
Shares owned after154,745
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Includes 271 shares acquired under the Issuer's 2017 Employee Stock Purchase Plan on May 29, 2026.